Antagonism has been demonstrated between clindamycin and erythromycin in vitro. Because of possible clinical significance, these two drugs should not be administered concurrently. Clindamycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Therefore, it should be used with caution in patient receiving such agents.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
